Skip to main content
. 2009 Jul 18;61(11):965–976. doi: 10.1016/j.addr.2009.07.001

Table 2.

Analysis of anti-therapeutic antibody responses in relation to neo epitope and Tregitope content.

Monoclonal antibodies High Tregitope content (%) Low Tregitope content (%)
Low neo epitope content Nuvion (0) Synagis (1)
High neo epitope content Humira (12) Rituxan (27)